Susquehanna Fundamental Investments’s Solid Biosciences SLDB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116,525	Closed	-$657K	–	668
2025 Q4	$657K	Hold	116,525	–	–	0.02%	395
2025 Q3	$719K	Sell	116,525 -25,027	-18%	-$146K	0.03%	385
2025 Q2	$689K	Hold	141,552	–	–	0.02%	506
2025 Q1	$524K	Buy	+141,552	New	+$606K	0.01%	832
2024 Q2	$91.9K	Buy	+16,200	New	+$145K	﹤0.01%	901
2021 Q4	–	Sell	-2,857	Closed	-$102K	–	1734
2021 Q3	$102K	Buy	2,857 +1,585	+125%	+$67.3K	﹤0.01%	1619
2021 Q2	$70K	Sell	1,272 -228	-15%	-$15.1K	﹤0.01%	1601
2021 Q1	$124K	Buy	1,500 +353	+31%	+$39.1K	﹤0.01%	1448
2020 Q4	$130K	Buy	+1,147	New	+$72.5K	﹤0.01%	1399

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Susquehanna Fundamental Investments's SLDB Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 116,525 shares — an estimated $657K sold.

Susquehanna Fundamental Investments first reported a position in SLDB in Q4 2020 and held it in 9 quarters. The position peaked at $719K in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

Susquehanna Fundamental Investments reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
Susquehanna Fundamental Investments sold 116,525 Solid Biosciences shares in Q1 2026, an estimated $657K.
Susquehanna Fundamental Investments first reported a position in Solid Biosciences in Q4 2020 and held it in 9 quarters.
Susquehanna Fundamental Investments's Solid Biosciences position peaked at $719K in Q3 2025.
150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.